Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 3/20 | 0.71 |
| ▸ | LMNA | P02545 | 5/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 7/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9567343 | 1.00 | MCL1 (0.71) | MCL1LMNAALDH1A1KDM4EHTT | |
| SCHEMBL10936802 | 0.86 | MCL1 (0.76) | MCL1LMNAALDH1A1KDM4EHTT | |
| SCHEMBL15081 | 0.86 | MCL1 (0.76) | MCL1LMNAALDH1A1KDM4EHTT | |
| SCHEMBL8773598 | 0.86 | MCL1 (0.76) | MCL1LMNAALDH1A1KDM4EHTT | |
| SCHEMBL15082 | 0.86 | MCL1 (0.76) | MCL1LMNAALDH1A1KDM4EHTT | |
| Ammonia Solution, Strong SCHEMBL434911 | 0.85 | MCL1 (0.73) | MCL1LMNAALDH1A1KDM4EHTT | |
| SCHEMBL14889223 | 0.83 | MCL1 (0.71) | MCL1LMNAALDH1A1KDM4EHTT | |
| SCHEMBL9361177 | 0.80 | MCL1 (0.67) | MCL1LMNAALDH1A1KDM4EHTT | |
| SCHEMBL9361168 | 0.80 | MCL1 (0.67) | MCL1LMNAALDH1A1KDM4EHTT | |
| SCHEMBL8756597 | 0.80 | MCL1 (0.66) | MCL1LMNAALDH1A1KDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100068235-A1 | Individualizable dosage form | Searete LLC, a limited liability corporation of Deleware | 2010-03-18 | — | — | US | claimed |
| US-20140257841-A1 | EX VIVO MODIFIABLE MULTIPLE MEDICAMENT FINAL DOSAGE FORM | SEARETE LLC (US) | 2014-09-11 | — | — | US | disclosed |
| US-8753677-B2 | Ex vivo modifiable multiple medicament final dosage form | THE INVENTION SCIENCE FUND I, LLC (US) | 2014-06-17 | — | — | US | disclosed |
| US-20100068275-A1 | Personalizable dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068152-A1 | Ex vivo modifiable particle or polymeric based final dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068153-A1 | Ex vivo activatable final dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068254-A1 | Modifying a medicament availability state of a final dosage form | THE INVENTION SCIENCE FUND I, LLC | 2010-03-18 | — | — | US | disclosed |
| US-20100068266-A1 | Ex vivo-modifiable multiple-release state final dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100069821-A1 | Ex vivo modifiable medicament release-sites final dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068283-A1 | Ex VIVO modifiable particle or polymeric material medicament carrier | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068256-A1 | Ex vivo modifiable medicament release-substance | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068277-A1 | Ex vivo modifiable multiple medicament final dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100069887-A1 | Multiple chamber ex vivo adjustable-release final dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068278-A1 | Ex vivo modifiable medicament release-associations | SEARETE LLC, A LIMITED LIABLITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068233-A1 | Modifiable dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068235-A1 | Individualizable dosage form | Searete LLC, a limited liability corporation of Deleware | 2010-03-18 | — | — | US | disclosed |
| US-20100069822-A1 | System for ex vivo modification of medicament release state | SEARETE LLC, A LIMITED LIABLITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-6174645-B1 | BIOCOMPATIBILITY; NONTOXIC; ANTICOAGULANTS | UNIVERSITY OF PITTSBURGH | 2001-01-16 | — | — | US | disclosed |
| US-5990193-A | A PHOTOSENSITIVE CROSSLINKED POLYMER NETWORK OF BRANCHED MACROMERIC POLYMERS FUNCTIONALIZED WITH PHOTOCHROMIC MOIETIES, PREFERABLY CINNAMYLIDENE; CYCLIZATION AND PHOTOSCISSION USING DIFFERENT WAVELENGTHS; BIODEGRADABLE ?BANDAGES? | UNIVERSITY OF PITTSBURGH (US) | 1999-11-23 | — | — | US | disclosed |
| WO-1997022037-A1 | POLYMERS FOR REVERSIBLE PHOTOINDUCED SOL GEL TRANSITIONS | UNIVERSITY OF PITTSBURGH (US) | 1997-06-19 | — | — | WO | disclosed |